Analytical Data
-
Gene name
RPL6
- Application
-
Alternative Names
SHUJUN-2; TAXREB107; TXREB1; Neoplasm-related protein C140; Tax-responsive enhancer element-binding protein 107
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q02878
-
Expression Region
Ala2~Phe288
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL6, a key component of the ribosomal protein family, plays a crucial role in ribosome biogenesis and protein synthesis within eukaryotic cells. Research on RPL6 has gained significant attention due to its involvement in various cellular processes, including cell proliferation, stress response, and apoptosis. Notably, dysregulation of RPL6 expression has been implicated in several malignancies, making it a potential biomarker for cancer progression. Studies have shown that RPL6 can influence the translation of specific mRNAs, thereby impacting the expression of genes associated with tumorigenesis. Additionally, RPL6 has been linked to the regulation of the p53 tumor suppressor pathway, highlighting its significance in maintaining cellular homeostasis. The generation and study of RPL6 recombinant proteins are essential for elucidating its structure-function relationships and its interactions with other molecular players in the ribosomal assembly and function. Utilizing recombinant technology allows researchers to produce large quantities of RPL6 for biochemical assays and structural analyses, facilitating a deeper understanding of its role in ribosome function and its potential as a therapeutic target in cancer treatment. Overall, the investigation of RPL6 and its derivatives remains a vital area of research with promising implications in both fundamental biology and clinical applications.
